Steven L. Hoerter Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven L. Hoerter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven L. Hoerter. Steven L. Hoerter is in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Chief Commercial Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and SEE REMARKS in Clovis Oncology, Inc. ($CLVS) and Director in Ignyta, Inc. ($RXDX) and Director in Deciphera Pharmaceuticals, Inc. ($DCPH) and President & CEO in Deciphera Pharmaceuticals, Inc. ($DCPH) and President and CEO in Deciphera Pharmaceuticals, Inc. ($DCPH).
Latest Insider Trading Transactions of Steven L. Hoerter
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, CLVS, CNST, DCPH, RXDX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 43.19 | 2,450 | 105,828 | 40,695 | 43.1 K to 40.7 K (-5.68 %) |
| Mar 22 2021 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 42.39 | 700 | 29,672 | 43,145 | 43.8 K to 43.1 K (-1.60 %) |
| Jan 25 2021 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Option Exercise | M | 25.40 | 1,078 | 27,381 | 395,735 | |
| Jan 25 2021 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Buy | M | 25.40 | 1,078 | 27,381 | 43,845 | 42.8 K to 43.8 K (+2.52 %) |
| Aug 24 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Option Exercise | M | 25.40 | 187 | 4,750 | 396,813 | |
| Aug 24 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Buy | M | 25.40 | 187 | 4,750 | 42,767 | 42.6 K to 42.8 K (+0.44 %) |
| Jul 22 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Option Exercise | M | 25.40 | 188 | 4,775 | 397,000 | |
| Jul 22 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Buy | M | 25.40 | 188 | 4,775 | 42,580 | 42.4 K to 42.6 K (+0.44 %) |
| Jun 19 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Option Exercise | A | 25.40 | 187 | 4,750 | 397,188 | |
| Jun 19 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Buy | M | 25.40 | 187 | 4,750 | 42,392 | 42.2 K to 42.4 K (+0.44 %) |
| Jun 08 2020 | CNST | CONSTELLATION PHAR ... | Hoerter Steven L. | Option Exercise | A | 37.52 | 13,171 | 494,176 | 13,171 | ||
| Jun 01 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Option Exercise | A | 25.40 | 188 | 4,775 | 397,375 | |
| Jun 01 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Buy | M | 25.40 | 188 | 4,775 | 42,205 | 42 K to 42.2 K (+0.45 %) |
| Apr 23 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Option Exercise | A | 25.40 | 187 | 4,750 | 397,563 | |
| Apr 23 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Buy | M | 25.40 | 187 | 4,750 | 42,017 | 41.8 K to 42 K (+0.45 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Option Exercise | A | 25.40 | 2,250 | 57,150 | 397,750 | |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Option Exercise | A | 25.40 | 2,250 | 57,150 | 397,750 | |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 39.98 | 520 | 20,790 | 41,830 | 42.4 K to 41.8 K (-1.23 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 39.98 | 520 | 20,790 | 41,830 | 42.4 K to 41.8 K (-1.23 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 39.22 | 2,164 | 84,872 | 42,350 | 44.5 K to 42.4 K (-4.86 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 39.22 | 2,164 | 84,872 | 42,350 | 44.5 K to 42.4 K (-4.86 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 38.26 | 4,230 | 161,840 | 44,514 | 48.7 K to 44.5 K (-8.68 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 38.26 | 4,230 | 161,840 | 44,514 | 48.7 K to 44.5 K (-8.68 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 36.88 | 1,012 | 37,323 | 48,744 | 49.8 K to 48.7 K (-2.03 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 36.88 | 1,012 | 37,323 | 48,744 | 49.8 K to 48.7 K (-2.03 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 35.78 | 4,494 | 160,795 | 49,756 | 54.3 K to 49.8 K (-8.28 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Payment of Exercise | F | 35.78 | 4,494 | 160,795 | 49,756 | 54.3 K to 49.8 K (-8.28 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Buy | M | 25.40 | 2,250 | 57,150 | 54,250 | 52 K to 54.3 K (+4.33 %) |
| Mar 20 2020 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President and CEO | Buy | M | 25.40 | 2,250 | 57,150 | 54,250 | 52 K to 54.3 K (+4.33 %) |
| Jun 10 2019 | CNST | CONSTELLATION PHAR ... | Hoerter Steven L. | Director | Option Exercise | A | 9.12 | 13,171 | 120,120 | 13,171 | |
| Mar 20 2019 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President & CEO | Option Exercise | A | 25.40 | 400,000 | 10,160,000 | 400,000 | |
| Mar 20 2019 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President & CEO | Grant | A | 0.00 | 30,000 | 0 | 52,000 | 22 K to 52 K (+136.36 %) |
| Mar 20 2019 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | President & CEO | Grant | A | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
| Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 0.00 | 2,750 | 0 | 5,500 | |
| Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Payment of Exercise | F | 58.03 | 1,040 | 60,351 | 10,941 | 12 K to 10.9 K (-8.68 %) |
| Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 0.00 | 2,750 | 0 | 11,981 | 9.2 K to 12 K (+29.79 %) |
| Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Payment of Exercise | F | 52.82 | 5,769 | 304,719 | 9,231 | 15 K to 9.2 K (-38.46 %) |
| Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Sep 05 2018 | CNST | CONSTELLATION PHAR ... | Hoerter Steven L. | Director | Option Exercise | A | 9.05 | 26,342 | 238,395 | 26,342 | |
| Aug 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 60,650 | |
| Aug 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 74.92 | 2,050 | 153,586 | 0 | 2.1 K to 0 (-100.00 %) |
| Aug 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Jul 27 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 62,700 | |
| Jul 27 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 84.58 | 2,050 | 173,389 | 0 | 2.1 K to 0 (-100.00 %) |
| Jul 27 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Jul 24 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 64,750 | |
| Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 97.58 | 2,050 | 200,039 | 0 | 2.1 K to 0 (-100.00 %) |
| Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 66,800 | |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 85.76 | 2,050 | 175,808 | 0 | 2.1 K to 0 (-100.00 %) |
| May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Hoerter Steven L. | Director | Option Exercise | A | 25.73 | 24,000 | 617,520 | 24,000 | |
| Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 68,850 | |
| Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 85.95 | 2,050 | 176,198 | 0 | 2.1 K to 0 (-100.00 %) |
| Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 70,900 | |
| Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 84.65 | 2,050 | 173,533 | 0 | 2.1 K to 0 (-100.00 %) |
| Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 72,950 | |
| Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 78.63 | 2,050 | 161,192 | 0 | 2.1 K to 0 (-100.00 %) |
| Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 0.00 | 8,250 | 0 | 8,250 | |
| Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 77.70 | 33,000 | 2,564,100 | 33,000 | |
| Feb 12 2018 | RXDX | Ignyta, Inc. | Hoerter Steven L. | Director | Option Exercise | D | 8.35 | 11,666 | 97,411 | 0 | |
| Feb 12 2018 | RXDX | Ignyta, Inc. | Hoerter Steven L. | Director | Option Exercise | D | 6.40 | 24,000 | 153,600 | 0 | |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 25,000 | 994,000 | 75,000 | |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 74.83 | 25,000 | 1,870,750 | 0 | 25 K to 0 (-100.00 %) |
| Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 25,000 | 994,000 | 25,000 | 0 to 25 K |
| Jun 19 2017 | RXDX | Ignyta, Inc. | Hoerter Steven L. | Director | Option Exercise | A | 8.35 | 11,666 | 97,411 | 11,666 | |
| Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
| Dec 09 2016 | RXDX | Ignyta, Inc. | Hoerter Steven L. | Director | Option Exercise | A | 6.40 | 24,000 | 153,600 | 24,000 | |
| Feb 18 2016 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 39.76 | 100,000 | 3,976,000 | 100,000 | |
| Mar 09 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Option Exercise | M | 11.02 | 20,000 | 220,400 | 26,206 | |
| Mar 09 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Sell | S | 80.00 | 20,000 | 1,600,000 | 0 | 20 K to 0 (-100.00 %) |
| Mar 09 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Buy | M | 11.02 | 20,000 | 220,400 | 20,000 | 0 to 20 K |
| Mar 04 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Option Exercise | A | 79.05 | 35,000 | 2,766,750 | 35,000 | |
| Feb 19 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Option Exercise | M | 11.02 | 10,000 | 110,200 | 46,206 | |
| Feb 19 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Sell | S | 72.00 | 10,000 | 720,000 | 0 | 10 K to 0 (-100.00 %) |
| Feb 19 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Buy | M | 11.02 | 10,000 | 110,200 | 10,000 | 0 to 10 K |
| Jan 20 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Option Exercise | M | 11.02 | 10,000 | 110,200 | 56,206 | |
| Jan 20 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Sell | S | 67.00 | 10,000 | 670,000 | 0 | 10 K to 0 (-100.00 %) |
| Jan 20 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Buy | M | 11.02 | 10,000 | 110,200 | 10,000 | 0 to 10 K |
| Jan 15 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Option Exercise | M | 11.02 | 10,000 | 110,200 | 66,206 | |
| Jan 15 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Sell | S | 62.00 | 10,000 | 620,000 | 0 | 10 K to 0 (-100.00 %) |
| Jan 15 2015 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Buy | M | 11.02 | 10,000 | 110,200 | 10,000 | 0 to 10 K |
| Jan 14 2014 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Option Exercise | A | 73.98 | 65,000 | 4,808,700 | 65,000 | |
| Jun 06 2013 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Option Exercise | M | 11.02 | 10,000 | 110,200 | 76,206 | |
| Jun 06 2013 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Sell | S | 73.06 | 10,000 | 730,600 | 0 | 10 K to 0 (-100.00 %) |
| Jun 06 2013 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | See Remarks | Buy | M | 11.02 | 10,000 | 110,200 | 10,000 | 0 to 10 K |
| Mar 04 2013 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | SEE REMARKS | Option Exercise | A | 21.81 | 60,000 | 1,308,600 | 60,000 | |
| Mar 05 2012 | CLVS | Clovis Oncology, I ... | Hoerter Steven L. | SEE REMARKS | Option Exercise | A | 24.74 | 60,000 | 1,484,400 | 60,000 |
Page: 1